Harridge Stephen D R, Velloso Cristiana P
Division of Applied Biomedical Research, School of Biomedical and Health Sciences, 4.14 Shepherd's House Guy's Campus, King's College London, London SE1 1UL, UK.
Essays Biochem. 2008;44:125-38. doi: 10.1042/BSE0440125.
Gene doping is the misuse of gene therapy to enhance athletic performance. It has recently been recognised as a potential threat and subsequently been prohibited by the World Anti-Doping Agency. Despite concerns with safety and efficacy of gene therapy, the technology is progressing steadily. Many of the genes/proteins which are involved in determining key components of athletic performance have been identified. Naturally occurring mutations in humans as well as gene-transfer experiments in adult animals have shown that altered expression of these genes does indeed affect physical performance. For athletes, however, the gains in performance must be weighed against the health risks associated with the gene-transfer process, whereas the detection of such practices will provide new challenges for the anti-doping authorities.
基因兴奋剂是对基因治疗的滥用,以提高运动成绩。它最近被认为是一种潜在威胁,随后被世界反兴奋剂机构禁止。尽管人们对基因治疗的安全性和有效性存在担忧,但该技术仍在稳步发展。许多与决定运动成绩关键因素相关的基因/蛋白质已被识别。人类的自然突变以及成年动物的基因转移实验表明,这些基因表达的改变确实会影响身体表现。然而,对于运动员来说,成绩的提升必须与基因转移过程带来的健康风险相权衡,而检测此类行为将给反兴奋剂机构带来新的挑战。